US FDA given different prescriptions for health of tobacco and food programmes

The Reagan-Udall Foundation’s reports on the US Food and Drug Administration (FDA) provide “substantially different future policy implications” for the different FDA programmes investigated, according to a lawyer specialising in FDA regulation.

The report on the FDA’s Human Foods Program emphasises specifics for the agency’s organisational structure unlike the recommendations in the report on the FDA’s Center for Tobacco Products (CTP), which has a more operational focus, urging a more proactive approach to enforcement, attorney Joshua Ari Van De Riet told TobaccoIntelligence.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation